Site icon Business Manchester

EMIS Group Expands Technological Capabilities with New Acquisition

EMIS Group Expands Technological Capabilities with New Acquisition

EMIS Group, a leader in healthcare software, has strategically acquired innovative tech firm Dovetail Lab. This move enhances EMIS’s technological framework and market reach in the healthcare sector.

Founded in 2017, Dovetail Lab specialises in blockchain technology, offering solutions for secure data transactions. EMIS’s acquisition marks a forward-thinking strategy to integrate blockchain with existing health services.

In a decisive strategy to bolster its technological infrastructure, EMIS Group has acquired Dovetail Lab, a burgeoning tech firm specialising in blockchain solutions for healthcare. This acquisition, valued at £2.5 million, reflects EMIS’s commitment to innovative healthcare solutions and underscores the significant role of blockchain technology in transforming patient data management. The move signifies EMIS’s proactive approach in enhancing data security and operational efficiency.

The software by Dovetail Lab employs blockchain to deliver unparalleled data security and trust. Accountability is enhanced as each transaction is logged, ensuring transparency in data handling. Such robust frameworks mitigate data misuse and offer peace of mind to patients and healthcare providers alike, setting a new standard in digital healthcare solutions.

The incorporation of Dovetail’s team is expected to accelerate the development of new solutions, fostering an environment that encourages innovation and leverages the strengths of both companies. This will potentially lead to transformative changes in the healthcare software landscape.

Blockchain’s inherent security features address long-standing challenges in healthcare data management, offering solutions that ensure confidentiality and integrity of sensitive information. The utilisation of such technology is anticipated to vastly improve the accuracy and reliability of patient records.

The deal is a significant step in consolidating EMIS’s market presence, aimed at leveraging the capabilities of its community pharmacy division to drive growth and innovation across its services.

By investing in breakthrough technologies and unifying its subsidiaries, EMIS is reinforcing its status as a leader in healthcare innovation. This approach not only broadens its service capabilities but is also set to redefine standards within the industry.

Through strategic acquisitions and investments, EMIS is poised to harness advanced technologies to revolutionise healthcare service delivery. Its commitment to innovation and operational excellence continues to drive its leadership in the sector.


EMIS Group’s latest acquisitions highlight its strategic direction towards strengthening its technological framework. By incorporating cutting-edge blockchain technology and consolidating its subsidiaries, EMIS is set to enhance healthcare services.

These strategic moves not only bolster EMIS’s market position but also set a benchmark for future innovations in healthcare technology.

Exit mobile version